Metraipolis › archive › dc_fbf3ec8d8acb

Multi-Fidelity Gaussian Processes for Translational Modelling of Clinical Outcomes — arXiv:2609.05007

Source
arXiv (en)
Original
https://arxiv.org/abs/2609.05007
License (as archived)
CC0-1.0
Archived
2026-10-16T23:09:50.337Z
SHA-256 of the archived text
193a25357633428d4249dd17fe48ea8bc87a0e472499dfba8b77c2b2ccfc5a4e
Stable URL of this page
https://metraipolis.com/documento/dc_fbf3ec8d8acb

How to cite

Multi-Fidelity Gaussian Processes for Translational Modelling of Clinical Outcomes — arXiv:2609.05007 — arXiv (en), https://arxiv.org/abs/2609.05007 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_fbf3ec8d8acb (Metraipolis archive dc_fbf3ec8d8acb, sha256 193a25357633428d4249dd17fe48ea8bc87a0e472499dfba8b77c2b2ccfc5a4e)
BibTeX
@misc{dcfbf3ec8d8acb,
  title = {Multi-Fidelity Gaussian Processes for Translational Modelling of Clinical Outcomes — arXiv:2609.05007},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2609.05007},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_fbf3ec8d8acb; sha256 193a25357633428d4249dd17fe48ea8bc87a0e472499dfba8b77c2b2ccfc5a4e},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2609.05007. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Bridging the gap between animal and human experiments remains a major challenge in translational medicine, particularly in early drug development. Progress is constrained by financial cost, the difficulty of integrating heterogeneous in vitro and in vivo data, and the desire to reduce the use of animal testing balanced against minimising the risk to human participants. We present a statistical machine learning framework using multi-fidelity Gaussian processes, in which animal studies are considered as lower fidelity but informative approximations to human experiments. This allows cross-species similarities and nonlinear exposure-response relationships to be learned simultaneously, enabling principled extrapolation between species while quantifying uncertainty. By leveraging information from multiple experimental fidelities, our method improves estimation of clinically relevant quantities of interest and supports the replacement, reduction, and refinement of in vivo testing. We first illustrate this approach in a simulated scenario, before validating it on real clinical data. We simulate data for drug-induced QT-interval prolongation, a key cardiac safety assessment required for regulatory approval. This framework provides a probabilistic surrogate capable of integrating in vitro pharmacology, animal experiments and human data within a unified statistical model. Crucially, it achieves this at no additional experimental cost while also enabling transfer learning across compounds. As a result, predictions and uncertainty quantification for new drugs can be generated from in vitro findings alone, providing additional efficiency gains and accelerating decision making. For validation, we use a clinical dataset measuring change in heart rate under autonomic blockade, which represents some of the challenges commonly found in multi-species datasets.

Tema degli esploratori: statistica e scienza dei dati (retro-catalogo arXiv: annunci del 2026-09-07 in stat.AP).
Categorie arXiv: Applications (stat.AP).
Pagina del lavoro: https://arxiv.org/abs/2609.05007 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-16T22:51:09.094Z dalla pagina https://arxiv.org/catchup/stat.AP/2026-09-07?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).